Publications by authors named "Pascal Robidou"

Claim this Profile
S
Simultaneous quantification of four hormone therapy drugs by LC-MS/MS: Clinical applications in breast cancer patients.
Bochra Mansour, Clarice Ngo, Dimitri Schlemmer, Pascal Robidou, Juliette Blondel

J Pharm Biomed Anal· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of plasma concentration of Belimumab by LC-MS/MS: Method development, validation, and clinical application.
Clémence Marin, Gaëlle Noé, Dimitri Schlemmer, Quentin Beaulieu, Pascal Robidou

J Pharm Biomed Anal· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple and accurate quantitative analysis of cefiderocol and ceftobiprole in human plasma using liquid chromatography-isotope dilution tandem mass spectrometry: interest for their therapeutic drug monitoring and pharmacokinetic studies.
Benoit Llopis, Alexandre Bleibtreu, Dimitri Schlemmer, Pascal Robidou, Olivier Paccoud

Clin Chem Lab Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and clinical validation of a simple and fast UPLC-ESI-MS/MS method for simultaneous quantification of nine kinase inhibitors and two antiandrogen drugs in human plasma: Interest for their therapeutic drug monitoring.
Benoit Llopis, Pascal Robidou, Nadine Tissot, Bruno Pinna, Paul Gougis

J Pharm Biomed Anal· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of the HIV-integrase inhibitor raltegravir (MK-0518) in human plasma by high-performance liquid chromatography with fluorescence detection.
Jean-Marie Poirier, Pascal Robidou, Patrice Jaillon

J Chromatogr B Analyt Technol Biomed Life Sci· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography.
Jean-Marie Poirier, Pascal Robidou, Patrice Jaillon

Ther Drug Monit· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous determination of the six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir, and saquinavir) plus M8 nelfinavir metabolite and the nonnucleoside reverse transcription inhibitor efavirenz in human plasma by solid-phase extraction and column liquid chromatography.
Jean-Marie Poirier, Pascal Robidou, Patrice Jaillon

Ther Drug Monit· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis